Kiwa Bio-Tech Products Group Corporation
KWBT · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Revenue | $9 | $11 | $11 | $10 |
| % Growth | -21.4% | 0.6% | 14.5% | – |
| Cost of Goods Sold | $7 | $8 | $8 | $7 |
| Gross Profit | $1 | $3 | $3 | $2 |
| % Margin | 16.3% | 23.5% | 29% | 22.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $2 | $0 |
| Operating Expenses | $1 | $1 | $4 | $1 |
| Operating Income | $0 | $2 | -$1 | $1 |
| % Margin | 0.5% | 16.9% | -6.8% | 12.4% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$0 |
| Pre-Tax Income | -$5 | $1 | -$2 | $1 |
| Tax Expense | $0 | $0 | $1 | $1 |
| Net Income | -$5 | $0 | -$2 | $0 |
| % Margin | -59% | 2.8% | -20.6% | 4.1% |
| EPS | -0.22 | 0.02 | -0.12 | 0.02 |
| % Growth | -1,200% | 116.7% | -700% | – |
| EPS Diluted | -0.22 | 0.01 | -0.12 | 0.02 |
| Weighted Avg Shares Out | 23 | 20 | 19 | 17 |
| Weighted Avg Shares Out Dil | 23 | 23 | 19 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $2 | -$1 | $1 |
| % Margin | 0.5% | 17.8% | -6.4% | 12.8% |